Received Nov 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | U8823AA | OT |
administration of flublok to 6 years of age with no reported ae; Initial information received on 17-Nov-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 6 years old and unknown gender patient who received influenza trivalent recombinant vaccine [Flublok TIV] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received 0.5 ml of suspect influenza trivalent recombinant vaccine Solution for injection of standard strength, frequency once with lot U8823AA and expiry date 31-May-2026 via unknown route in unknown administration site for immunization with no reported adverse event (product administered to patient of inappropriate age) (Latency same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: US-SA-2025SA346389: